Immediate Impact
1 from Science/Nature 73 standout
Citing Papers
Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials
2023 Standout
Protein posttranslational modifications in health and diseases: Functions, regulatory mechanisms, and therapeutic implications
2023 Standout
Works of Mirna Golemović being referenced
AMN107, a novel aminopyrimidine inhibitor of p190 Bcr‐Abl activation and of in vitro proliferation of Philadelphia‐positive acute lymphoblastic leukemia cells
2005
AMN107, a Novel Aminopyrimidine Inhibitor of Bcr-Abl, Has In vitro Activity against Imatinib-Resistant Chronic Myeloid Leukemia
2005
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Mirna Golemović | 226 | 76 | 164 | 122 | 22 | 314 | |
| Sara Vieira | 157 | 109 | 101 | 53 | 14 | 325 | |
| A Domingo | 196 | 145 | 267 | 141 | 22 | 371 | |
| Arta Dreimane | 283 | 25 | 238 | 119 | 17 | 334 | |
| A. Megan Cornelison | 239 | 86 | 141 | 53 | 16 | 312 | |
| Nicola Orofino | 165 | 61 | 147 | 47 | 22 | 255 | |
| Alessandra Cupri | 205 | 64 | 85 | 32 | 26 | 296 | |
| Nelma Clementino | 247 | 18 | 121 | 102 | 17 | 335 | |
| H. L. Seewann | 204 | 85 | 108 | 64 | 27 | 319 | |
| Elisa Zuffa | 209 | 105 | 211 | 90 | 24 | 306 | |
| Yasuji Kouzai | 258 | 19 | 150 | 89 | 20 | 307 |
All Works
Login with ORCID to disown or claim papers
Loading papers...